Back to search

Article

Targeting NAAA counters dopamine neuron loss and symptom progression in mouse models of Parkinson’s disease

2022-02-11

Abstract excerpt

<h4>ABSTRACT</h4> The lysosomal cysteine hydrolase N -acylethanolamine acid amidase (NAAA) deactivates the lipidderived mediator palmitoylethanolamide (PEA), an endogenous PPAR-α agonist that is critically involved in the control of inflammation and nociception. In this study, we asked whether NAAA-regulated PEA signaling might contribute to the pathogenesis of Parkinson’s disease (PD), a neurodegenerative disor...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
93f77874-7671-5330-8f73-0e2a764a1bca
DOI
10.1101/2022.02.10.479850
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Targeting NAAA counters dopamine neuron loss and symptom progression in mouse models of Parkinson’s diseaseDOI 10.1101/2022.02.10.479850
Select a neighboring publication to make it the new centre.